...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: from IR "Hepalink does not own Zenith shares."

Thanks for setting the record straight RVXoldtimer, much appreicated.

 

just an fyi on another note to all , ive done as much whining & wrote down as much frustration as anyone here.Having said that if ya got a itch/question you need scratched/answered send to IR & say its from the agora board.

 

I sent this Chris a bit a go:

"Hi again Chris,

Just wanted you to be aware that these questions come from the really only active board/discussion/agoracom/zenith where most long time shareholders chat so we feel it’s very important these 3 questions are asked. Our voice is loud but rarely heard it seems so we feel it’s very important for management to know this & to please do their best to address the 3 questions. We may have one or two more this evening that I will forward or from other members on agoracom. We would hope that these questions receive strong consideration in the Q & A  tmr afternoon.
Good luck to us all!
 
Kind regards,
xxxxx"
 
 
 
 
Share
New Message
Please login to post a reply